Andere Sprachen Fresenius SE & Co. KGaA

Aktien

578560

DE0005785604

FRE

Gesundheitspflege Einrichtungen

Markt geschlossen - Xetra Andere Börsenplätze 17:39:11 10.02.2026			Nachbörslich 19:16:28
49,98 ^EUR	-0,08 %		50,00	+0,04 %

09.02.	Fresenius Kabi geht Partnerschaft mit US-Unternehmen Phlow ein, um Lieferkette für Epinephrin aufzubauen	RE
09.02.	Fresenius und Phlow kooperieren zur Stärkung der US-Versorgung mit unerlässlichen Arzneimitteln	RE

Andere Sprachen

09.02.	Fresenius Kabi enters partnership with U.S. Phlow to establish supply chain for epinephrine
09.02.	Fresenius and Phlow partner to strengthen U.S. supply of essential medicine
09.02.	Fresenius : and Phlow Partner to Strengthen U.S. Supply of Essential Medicine
09.02.	Fresenius SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
05.02.	Fresenius SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
28.01.	Fresenius SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
28.01.	BofA Expects Sustained 'Solid' Growth for Fresenius SE in Q4 2025; Buy Rating Kept
27.01.	German DAX Index Closes Lower; Puma Surges Amid Anta Deal
26.01.	Fresenius SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
26.01.	Donde el mercado aún no mira : "Diez valores europeos que cotizan con descuento"
19.01.	Fresenius and SAP intend to enter strategic partnership
19.01.	AI in Healthcare: SAP and Fresenius Accelerate Digital Healthcare Delivery
14.01.	Fresenius s'engage dans une collaboration avec TQ Therapeutics
14.01.	Fresenius enters into strategic development agreement with TQ Therapeutics
14.01.	Fresenius : advances scalable cell therapy manufacturing with strategic-development agreement
12.01.	Record en séance, hésitations en clôture à la Bourse de Paris
23.12.	Fresenius says sale of Austrian project business and spa operations to Porr approved
23.12.	Fresenius : Sale of Austrian project business and spa operations to PORR approved
18.12.	Austria's Strabag cancels plans to acquire hospital operator VKMB
15.12.	Fresenius : Biopharma ‚Meet the Management‘ (December 14, 2025)
05.12.	Fresenius : Declaration of Conformity of Fresenius SE & Co. KGaA, December 2025
04.12.	Britain's Frasers backs Hugo Boss' strategy and executive team
04.12.	Fresenius : strengthens biomanufacturing capabilities through AI collaboration
03.12.	Hugo Boss stock slides as fashion brand warns on sales, profit
01.12.	Fresenius : Launches Denosumab Biosimilars in EU

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Filter

Schlagzeilen

Fresenius: Starke Ergebnisse im dritten Quartal - Biosimilars bleiben Wachstumstreiber

Am 05. November 2025 um 16:16 Uhr